Results 71 to 80 of about 1,135 (163)

Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium

open access: yes, 2013
The purpose of this study was to determine the prevalence of ocular surface squamous neoplasia (OSSN) coexisting with pterygia in South Florida and to study the treatment and related outcomes. Noninterventional retrospective study.
Sheth, Anoop   +7 more
core   +1 more source

DataSheet_1_Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target.pdf

open access: yes, 2023
Yes-associated protein-1 (YAP-1) is a Hippo system transcription factor, which serves as an oncogene in squamous cell carcinoma, and several solid tumors when the Hippo pathway is dysregulated.
Peter Julius (5549807)   +17 more
core   +1 more source

Clinico-Demographic Profile of patients with Ocular Surface Squamous Neoplasia in tertiary care Hospital of North India [PDF]

open access: yes, 2021
Background: Ocular surface squamous neoplasia (OSSN) is a term used to describe neoplastic epithelial abnormalities of conjunctiva and cornea, ranging from Squamous Dysplasia to Invasive Squamous Cell Carcinoma.
Vijay Kumar, Manpreet Kour, Madhu Balla
core   +1 more source

A Study of clinicopathological features and proliferation marker KI-67 expression in ocular surface squamous neoplasia [PDF]

open access: yes, 2017
BACKGROUND: Ocular Surface Squamous Neoplasia (OSSN), is the most common primary ocular surface neoplasm and in the later decades of life, the third most common tumor of the ocular region after Melanoma and Lymphoma.
Gokulakannan, R
core  

Evidence for the Influence of HPV and DNATV in Ocular Surface Squamous Neoplasia

open access: yes, 2021
Ocular surface squamous neoplasia (OSSN) is a rare cancer which consists of a spectrum of diseases ranging from non-invasive intra-epithelial dysplasia of the conjunctiva and cornea (CCIN) to invasive squamous cell carcinoma.
Kaur, Salan Preet
core  

Association between human papillomavirus infection and ocular surface squamous neoplasia in South Africa

open access: yesAfrican Vision and Eye Health
Background: Ocular surface squamous neoplasia (OSSN) is an epithelial tumour of the conjunctiva. Risk factors for developing this tumour include ultraviolet-B (UVB) exposure, human immunodeficiency virus (HIV) and human papillomavirus (HPV) infection ...
Roland Hollhumer   +2 more
doaj   +1 more source

Update on pharmacotherapy for ocular surface squamous neoplasia

open access: yesEye and Vision, 2019
The most frequently encountered non-pigmented tumor of the ocular surface is ocular surface squamous neoplasia (OSSN). Over the past two decades, the pharmacological management of OSSN has grown, with topical 5-fluorouracil, mitomycin, and interferon ...
Ghada Al Bayyat   +4 more
doaj   +1 more source

It Is All About the Angle: A Clinical and Optical Coherence Tomography Comparison of Corneal Ocular Surface Squamous Neoplasia and Corneal Pannus

open access: yes, 2023
Purpose: The aim of this study was to compare clinical characteristics and high-resolution optical coherence tomography (HR-OCT) findings between corneal ocular surface squamous neoplasia (OSSN) and corneal pannus.
Locatelli, Elyana   +7 more
core   +1 more source

Role of mitomycin C in the management of ocular surface squamous neoplasia

open access: yesKerala Journal of Ophthalmology, 2020
Background: Ocular surface squamous neoplasia (OSSN) in a broader terminology recently introduced in the field of ophthalmology that includes conjunctival malignancies which ranges from mild epithelial dysplasia to invasive squamous cell carcinoma.
C Menaka, Venkatesh Perumal, R Shankar
doaj   +1 more source

Clinical Presentation of Ocular Surface Squamous Neoplasia in Kenya. [PDF]

open access: yes, 2015
IMPORTANCE: There is a trend toward treating conjunctival lesions suspected to be ocular surface squamous neoplasia (OSSN) based on the clinical impression.
Ernest Ollando   +25 more
core   +1 more source

Home - About - Disclaimer - Privacy